Thirty-three US REITs utilized their at-the-market (ATM) offering programs during the recent quarter, raising $4.15 billion in aggregate proceeds. Healthcare REIT Welltower Inc. raised the most ...

TORONTO, May 29, 2026 (GLOBE NEWSWIRE) — (TSX: NPS.PR.A, NPS) – Canadian Large Cap Leaders Split Corp. (the “Company”) is pleased to announce that it has established an at-the-market equity program ...

STRC's dividend rate remained unchanged at 11.5% after the stock's monthly VWAP reached $99.62, allowing Strategy to keep shares trading close to their $100 target par value. Maintaining STRC near par ...

Prepare for an inspiring career with a degree from the College of Engineering and Applied Science. The professional MS in Creative Technology and Design (CTD) is a 33-credit hour program that teaches ...

A licensed attorney with nearly a decade of experience in content production, Valerie Catalano knows how to help readers digest complicated information about the law in an approachable way. Her ...

Intellia Therapeutics ( (NTLA)) just unveiled an announcement. On March 2, 2026, Intellia Therapeutics, Inc. amended its at-the-market equity offering agreement with Jefferies LLC, raising the total ...

Python’s lead narrows again, C holds the runner-up spot, C++ returns to third, and SQL climbs back above R in June’s top 10 rankings update. June’s TIOBE Index has the feel of a rematch month. The top ...

In RIT’s industrial design BFA, you’ll create and develop innovative products for both consumers and manufacturers with your choice of diverse industries to work in. Accelerated Degree Option: RIT’s ...

At the University of Dayton, we provide strong training in art and design professional degree areas, offering you opportunities to earn a bachelor of arts, bachelor of fine arts, minor or certificate ...

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-conviction stock picks and new investing ...

Faster drug discovery, optimized drug design, even programmable therapeutics: AI is impacting R&D. Data and development bottlenecks remain. You have full access to this article via your institution.